Structures by: Borodi G.
Total: 26
C26H25ClN2O3
C26H25ClN2O3
Organic Process Research & Development (2018) 22, 10 1365
a=7.6270(10)Å b=38.007(4)Å c=8.5629(12)Å
α=90.00° β=108.118(15)° γ=90.00°
C16H21NO2
C16H21NO2
Organic Process Research & Development (2018) 22, 10 1365
a=5.0450(4)Å b=12.4178(11)Å c=23.187(2)Å
α=90.00° β=90.00° γ=90.00°
C16H21NO2
C16H21NO2
Organic Process Research & Development (2018) 22, 10 1365
a=4.99000Å b=11.92000Å c=22.95000Å
α=90° β=90° γ=90°
C26H25ClN2O3
C26H25ClN2O3
Organic Process Research & Development (2018) 22, 10 1365
a=7.52000Å b=38.53000Å c=8.44000Å
α=90° β=107.820° γ=90°
(La0.8 Al0.2) (B O3)
Al0.2BLa0.8O3
Modern Physics Letters B (2002) 16, 915-921
a=5.871Å b=5.099Å c=8.239Å
α=90° β=90° γ=90°
Promethazine Hydrochloride fumaric acid
2(C17H21N2S),2(Cl),C4H4O4
Acta Crystallographica Section C (2019) 75, 2 107-119
a=8.7741(3)Å b=25.8762(7)Å c=8.6007(3)Å
α=90° β=102.920(3)° γ=90°
Promethazine hydrochloride succinic acid
2(C17H21N2S),2(Cl),C4H6O4
Acta Crystallographica Section C (2019) 75, 2 107-119
a=8.8247(3)Å b=26.4201(7)Å c=8.7393(4)Å
α=90° β=103.070(4)° γ=90°
Promethazine hydrochloride oxalic acid
2(C17H21N2S),2(Cl),C2H2O4
Acta Crystallographica Section C (2019) 75, 2 107-119
a=10.5507(2)Å b=12.4382(2)Å c=14.2966(3)Å
α=90° β=100.445(2)° γ=90°
Promethazine Hydrochloride adipic acid
2(C17H21N2S),2(Cl),C6H10O4
Acta Crystallographica Section C (2019) 75, 2 107-119
a=8.8988(2)Å b=27.7992(5)Å c=8.7933(2)Å
α=90° β=103.484(2)° γ=90°
Promethazine oxalic acid
C17H21N2S,C2HO4
Acta Crystallographica Section C (2019) 75, 2 107-119
a=8.6840(5)Å b=11.3871(5)Å c=20.0923(11)Å
α=104.106(4)° β=90.386(4)° γ=108.340(5)°
Β-cyclodextrin mefenamic acid inclusion complex
C55.5H13.5N0.9O36.8
Acta Crystallographica Section B (2002) 58, 6 1036-1043
a=15.4797(9)Å b=25.5892(15)Å c=9.2973(5)Å
α=90.0° β=98.976(7)° γ=90.0°
Β-cyclodextrin/mefenamic acid inclusion complex
C55.5H13.5N0.9O36.8
Acta Crystallographica Section B (2002) 58, 6 1036-1043
a=15.4797(5)Å b=25.5892(10)Å c=9.2973(4)Å
α=90.0° β=98.976(3)° γ=90.0°
?
C11H13N3O2S2
Acta Crystallographica Section B (2010) 66, 6 615-621
a=8.5364(2)Å b=15.0148(3)Å c=21.3846(3)Å
α=90.0° β=90.0° γ=90.0°
C42H70O35,C8H14O2S2,9(H2O)
C42H70O35,C8H14O2S2,9(H2O)
Acta Crystallographica Section B (2012) 68, 2 164-170
a=18.8929Å b=24.4634Å c=15.7376Å
α=90.0° β=110.5195° γ=90.0°
Hydrated sodium cytidine-5'-monophosphate
2Na1,C9H4N3O8P2,6.5H6O
Acta Crystallographica Section E (2001) 57, 11 m514-m516
a=14.042(2)Å b=8.924(2)Å c=16.091(3)Å
α=90.00° β=94.410(2)° γ=90.00°
5,5-Dimethyl-2-[6-methyl-2-(methylsulfanyl)pyrimidin-4-yloxy]- 1,3,2-dioxaphosphorinane-2-thione
C11H17N2O3PS2
Acta Crystallographica Section C (2002) 58, 5 o280-o281
a=9.900(2)Å b=9.330(2)Å c=17.010(3)Å
α=90° β=90.23(2)° γ=90°
<i>N</i>-Butyl-4-butylimino-2-methylpentan-2-aminium (<i>E</i>)-quercetinate
C14H31N2,C15H9O7
Acta Crystallographica Section E (2012) 68, 8 o2450
a=11.4017(7)Å b=13.1730(5)Å c=19.1961(9)Å
α=90.00° β=104.438(6)° γ=90.00°
Cl,C17H21N2S
Cl,C17H21N2S
Crystal Growth & Design (2012) 12, 12 5846
a=14.8123(8)Å b=8.3170(2)Å c=15.5334(8)Å
α=90.00° β=117.696(7)° γ=90.00°
Cl,C17H21N2S
Cl,C17H21N2S
Crystal Growth & Design (2012) 12, 12 5846
a=14.9293(6)Å b=8.3361(2)Å c=15.5173(6)Å
α=90.00° β=118.565(5)° γ=90.00°
Cl,C17H20.36N2S
Cl,C17H20.36N2S
Crystal Growth & Design (2012) 12, 12 5846
a=14.8724(8)Å b=8.2589(3)Å c=15.3578(8)Å
α=90.00° β=118.665(7)° γ=90.00°
Cl,C17H21N2S
Cl,C17H21N2S
Crystal Growth & Design (2012) 12, 12 5846
a=14.9859(9)Å b=8.3369(3)Å c=15.5132(10)Å
α=90.00° β=118.882(8)° γ=90.00°
Cl,C17H21N2S
Cl,C17H21N2S
Crystal Growth & Design (2012) 12, 12 5846
a=14.8149(13)Å b=8.3237(5)Å c=15.5201(12)Å
α=90.00° β=117.588(11)° γ=90.00°
C26H29Cl2N4O4,C2HO4
C26H29Cl2N4O4,C2HO4
Crystal Growth & Design (2013) 13, 10 4295
a=10.51506(16)Å b=13.3330(2)Å c=20.3036(3)Å
α=90.00° β=96.6413(14)° γ=90.00°
C26H28Cl2N4O4,C4H4O4
C26H28Cl2N4O4,C4H4O4
Crystal Growth & Design (2013) 13, 10 4295
a=10.5094(6)Å b=11.7425(6)Å c=13.4568(5)Å
α=96.238(4)° β=98.973(4)° γ=105.330(5)°
C26H28Cl2N4O4,C4H5O4
C26H28Cl2N4O4,C4H5O4
Crystal Growth & Design (2013) 13, 10 4295
a=10.5261(8)Å b=11.7297(9)Å c=13.4580(11)Å
α=95.287(6)° β=99.302(7)° γ=104.429(7)°
C26H28Cl2N4O4,C6H10O4
C26H28Cl2N4O4,C6H10O4
Crystal Growth & Design (2013) 13, 10 4295
a=5.8721(3)Å b=8.3797(4)Å c=34.4919(14)Å
α=92.623(4)° β=93.859(4)° γ=103.791(4)°